Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial
O'Brien, Susan, Prof, Furman, Richard R, MD, Coutre, Steven E, Prof, Sharman, Jeff P, MD, Burger, Jan A, MD, Blum, Kristie A, MD, Grant, Barbara, MD, Richards, Donald A, MD, Coleman, Morton, Prof, Wierda, William G, MD, Jones, Jeffrey A, MD, Zhao, Weiqiang, MD, Heerema, Nyla A, Prof, Johnson, Amy J, PhD, Izumi, Raquel, PhD, Hamdy, Ahmed, MD, Chang, Betty Y, PhD, Graef, Thorsten, MD, Clow, Fong, ScD, Buggy, Joseph J, PhD, James, Danelle F, MD, Byrd, John C, Prof
Published in The lancet oncology (01.01.2014)
Published in The lancet oncology (01.01.2014)
Get full text
Journal Article
A Phase I/II Trial of Panobinostat in Combination with Lenalidomide in Patients with Relapsed or Refractory Hodgkin Lymphoma
Maly, Joseph J., MD, Christian, Beth A., MD, Zhu, Xiaohua, PhD, Wei, Lai, PhD, Sexton, Jennifer L., MS, Jaglowski, Samantha M., MD, Devine, Steven M., BS MD, Fehniger, Todd A., PhD MD, Wagner-Johnston, Nina D., MD, Phelps, Mitch A., PhD, Bartlett, Nancy L., MD, Blum, Kristie A., MD
Published in Clinical lymphoma, myeloma and leukemia (01.06.2017)
Published in Clinical lymphoma, myeloma and leukemia (01.06.2017)
Get full text
Journal Article
Activity and Tolerability of Ibrutinib in Combination With Ofatumumab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Jaglowski, Samantha M., MD, MPH, Jones, Jeffrey A., MD, MPH, Flynn, Joseph M., DO, MPH, Andritsos, Leslie A., MD, Maddocks, Kami J., MD, Woyach, Jennifer A., MD, Blum, Kristie A., MD, Grever, Michael R., MD, Geyer, Susan Michelle, PhD, Heerema, Nyla A., PhD, Lozanski, Gerard, MD, Stefanos, Mona, BS, Hall, Nathan, MD, PhD, Nagar, Veena, MD, Munneke, Brian, PhD, West, Jamie-Sue, Neuenburg, Jutta K., MD, PhD, James, Danelle F., MD, MAS, Johnson, Amy J., PhD, Byrd, John C., MD
Published in Clinical lymphoma, myeloma and leukemia (01.06.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.06.2015)
Get full text
Journal Article
Long-Term Efficacy and Safety of Single-Agent Ibrutinib at 3 Years Follow-up in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL)
O’Brien, Susan M., MD, Jones, Jeffrey A., MD, MPH, Furman, Richard R., MD, Coutre, Steven E., MD, Flinn, Ian W., MD, PhD, Burger, Jan A., MD, PhD, Blum, Kristie A., MD, Sharman, Jeff P., MD, Wierda, William G., MD, PhD, Zhao, Weiqiang, MD, PhD, Heerema, Nyla A., PhD, Johnson, Amy J., PhD, Tran, Anh, BS, Zhou, Cathy, Bilotti, Elizabeth, MSN, James, Danelle F., MD, MAS, Byrd, John C., MD
Published in Clinical lymphoma, myeloma and leukemia (01.06.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.06.2015)
Get full text
Journal Article